Log In
Print this Print this

Latuda, lurasidone (SM-13496)

  Manage Alerts
Collapse Summary General Information
Company Sumitomo Dainippon Pharma Co. Ltd.
DescriptionSmall molecule antagonist of dopamine D2 receptor, serotonin (5-HT2A; 5-HT7) receptors and ADRA2C, and a partial agonist of serotonin (5-HT1A) receptor
Molecular Target Dopamine D2 receptor ; Adrenergic receptor alpha 2c (ADRA2C)
Mechanism of ActionDopamine D2 receptor antagonist; Serotonin (5-HT2A) receptor antagonist
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today